Efficacy of single-dose SA 14–14–2 vaccine against Japanese encephalitis: a case control study
- 1 September 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 358 (9284), 791-795
- https://doi.org/10.1016/s0140-6736(01)05967-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United StatesVaccine, 2000
- New initiatives for the control of Japanese encephalitis by vaccination:Vaccine, 2000
- Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infantsVaccine, 1999
- Use of the case-control approach in vaccine evaluation: efficacy and adverse effects.Epidemiologic Reviews, 1999
- Immunogenicity of Live Attenuated SA14–14–2 Japanese Encephalitis Vaccine—A Comparison of 1–and 3‐Month Immunization SchedulesThe Journal of Infectious Diseases, 1998
- Short‐Term Safety of Live Attenuated Japanese Encephalitis Vaccine (SA14–14–2): Results of a Randomized Trial with 26,239 SubjectsThe Journal of Infectious Diseases, 1997
- Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control studyThe Lancet, 1996
- A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy ChildrenNew England Journal of Medicine, 1992
- The Epidemiology of Japanese Encephalitis: Prospects for PreventionEpidemiologic Reviews, 1992
- Protection against Japanese Encephalitis by Inactivated VaccinesNew England Journal of Medicine, 1988